Celldex Therapeutics Inc (CLDX)
26.22
-0.18
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
26.24
+0.02
(+0.08%)
After-Hours: 20:00
Celldex Therapeutics Net Income (Quarterly): -42.12M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -42.12M |
| June 30, 2024 | -35.84M |
| March 31, 2024 | -32.81M |
| December 31, 2023 | -43.31M |
| September 30, 2023 | -38.26M |
| June 30, 2023 | -30.50M |
| March 31, 2023 | -29.36M |
| December 31, 2022 | -26.49M |
| September 30, 2022 | -26.78M |
| June 30, 2022 | -36.00M |
| March 31, 2022 | -23.05M |
| December 31, 2021 | -20.15M |
| September 30, 2021 | -20.45M |
| June 30, 2021 | -13.37M |
| March 31, 2021 | -16.54M |
| December 31, 2020 | -21.90M |
| September 30, 2020 | -14.22M |
| June 30, 2020 | -11.03M |
| March 31, 2020 | -12.62M |
| December 31, 2019 | -10.45M |
| September 30, 2019 | -11.41M |
| June 30, 2019 | -11.78M |
| March 31, 2019 | -17.24M |
| December 31, 2018 | -9.403M |
| September 30, 2018 | -7.243M |
| Date | Value |
|---|---|
| June 30, 2018 | -16.41M |
| March 31, 2018 | -118.13M |
| December 31, 2017 | -3.841M |
| September 30, 2017 | -26.36M |
| June 30, 2017 | -28.57M |
| March 31, 2017 | -34.26M |
| December 31, 2016 | -32.31M |
| September 30, 2016 | -29.60M |
| June 30, 2016 | -31.95M |
| March 31, 2016 | -34.67M |
| December 31, 2015 | -32.68M |
| September 30, 2015 | -31.98M |
| June 30, 2015 | -32.36M |
| March 31, 2015 | -30.17M |
| December 31, 2014 | -31.82M |
| September 30, 2014 | -28.08M |
| June 30, 2014 | -28.27M |
| March 31, 2014 | -29.90M |
| December 31, 2013 | -22.06M |
| September 30, 2013 | -23.14M |
| June 30, 2013 | -19.02M |
| March 31, 2013 | -17.33M |
| December 31, 2012 | -16.81M |
| September 30, 2012 | -15.03M |
| June 30, 2012 | -13.77M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-43.31M
Minimum
Dec 2023
-10.45M
Maximum
Dec 2019
-25.26M
Average
-24.77M
Median
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -15.12M |
| Electromed Inc | 1.474M |
| Xtant Medical Holdings Inc | -5.024M |
| Senseonics Holdings Inc | -23.98M |
| Myomo Inc | -0.9664M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.191M |
| Total Expenses (Quarterly) | 55.32M |
| EPS Diluted (Quarterly) | -0.64 |
| Enterprise Value | 983.55M |
| Profit Margin (Quarterly) | -1.32K% |
| Earnings Yield | -9.84% |
| Normalized Earnings Yield | -10.93 |